Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfimeprase for Restoring Function in Occluded Central Venous Catheters
NCT00073515Phase 2Completed
- Sponsor
- Oruka Therapeutics
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alfimeprase in central venous catheter occlusion (4 arms), sponsored by Oruka Therapeutics. Status: completed.
02
Drugs
alfimeprase
03
Conditions
central venous catheter occlusion
Beyond the preview
Go deeper on NCT00073515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073515.